Skip to main content
. 2017 Jul 26;8(5-6):330–337. doi: 10.1007/s12672-017-0303-8

Table 3.

Patient treatment summary

Patient Mutation Reason of IFN treatment Imaging exam (baseline and follow-up) New lesion on scintigraphy (FDG or MIBG) at baseline Response to IFN PERCIST 1.0/RECIST 1.1 Loco-regional treatment associated Duration of treatment with IFN SRE (n)
#1 SDHB Progression MRI and FDG-PET NA NA/NA None 4 months 0
#2 SDHB Progression within 7 months MRI and FDG-PET Yes, epidural compression on MRI SD/NE Kiphoplasty L1 and L4 54 months 2
#3 No Progression within 18 months FDG-PET and CT scan Yes SD/SD None 6 months, discontinuation for fever and arthralgiaa 0
#4 SDHB Progression within 10 months CT scan, FDG-PET, and octreo scan Yes PMR/NA Radiofrequency ablation and kiphoplasty T4, left iliac and left femur 25 months 0
#5 SDHB Progression within 9 months CT scan and octreo scan Yes SD/PD None 11 months 0
#6 SDHB Progression within 6 months FDG-PET Yes PMR/NE C1 to C5 radiation 19 months 1
#7 SDHB Progression within 6 months FDG-PET and CT scan Yes PMR/SD C1 radiation 14 months 1
#8 SDHB Progression within 7 months FDG-PET and MRI Yes SD/NA T2T3 surgery and radiation therapy 37 months, treatment discontinuation for asthenia 1
#9 No Progression within 6 months MIBG Yes SD/NE Sacro-iliac joint and right femur radiation therapy 17 months 1
#10 SDHB Progression within 8 months FDG-PET Yes PMR/NE Kiphoplasty L4, radiofrequency ablation T4, left rib and manubrium 40 months 1
#11 No Progression within 33 months MIBG and CT scan Yes SD/SD None 3 months, treatment until MIBG therapy 0
#12 SDHB Progression within 4 months FDG-PET and scan Yes SD/SD L2 radiofrequency ablation 7 months until progressive disease with new bone lesion 0
#13 No Progression within 3 months FDG-PET and MRI Yes NA/NA L4 and sacrum cryotherapy 37 months, pause 0
#14 No Progression within 3 months FDG-PET Yes SD/NE None 12.6 months, discontinued for skin toxicity, stabilization remains at last follow-up 0

NA not available, NE not evaluable, SD stable disease, PD progressive disease, PMR partial metabolic response

aPatient #3 was admitted to ICU 1 month after discontinuation of IFN-α for thoracic pain + hypertension + pulmonary edema + renal insufficiency which led to cardiac arrest